本文選題：臨床試驗 + 中西醫(yī)結合治療　； 參考：《中國中西醫(yī)結合雜志》2010年10期

【摘要】：發(fā)展中的醫(yī)學應當具有兩個重要的特點:創(chuàng)新性和可實踐性。在我國中醫(yī)和西醫(yī)兩種治療途徑并存的情況下,如何結合中醫(yī)和西醫(yī)各自的優(yōu)勢,做到真正提高現實世界中疾病的防治效果,最能體現這兩個特點。創(chuàng)新,是指要解決兩者聯用中不可避免地要遇到的許多新問題;可實踐,是指這種結合最終必須有助于解決臨床實踐中最需要解決的問題。臨床試驗是驗證這些問題是否得到解決的金標準。臨床試驗進入我國的時間并不長,但已經逐漸為我國臨床醫(yī)師所認識和接受,也受到中西醫(yī)結合臨床工作者的極大關注,近年來已有不少臨床試驗的結果得到發(fā)表,有些研究也得到國際學界的認可。本期發(fā)表的《關于中西醫(yī)結合心血管病臨床試驗若干問題的意見》在回顧既往經驗和教訓的基礎上,對我國中西醫(yī)結合心血管病臨床試驗的目的、設計、實施和應用等方面提出建議,不僅強調臨床試驗的科學性要求,而且強調從臨床需求出發(fā)立題,從一開始就考慮到試驗結果的可實踐性。這是因為中西醫(yī)結合臨床試驗不是簡單的單一藥物療效考核,而是旨在探索已經用于臨床的兩種治療途徑的最佳結合方式,或是確定最佳的中西醫(yī)結合治療方案。因此,本文不僅對心血管專業(yè),而且對其他專業(yè)的中西醫(yī)結合臨床試驗也有一定的參考價值。
[Abstract]:Developing medicine should have two important characteristics: innovation and practicability. In the case of the coexistence of two therapeutic approaches of Chinese medicine and western medicine, how to combine the advantages of traditional Chinese medicine and western medicine to truly improve the effect of disease prevention and treatment in the real world can best reflect these two characteristics. Innovation is to solve many new problems that will inevitably be encountered in the combination of the two, and practicability means that this combination must ultimately help to solve the problems that need to be solved most in clinical practice. Clinical trials are the gold standard for verifying that these problems are resolved. Clinical trials have not been in our country for a long time, but they have been gradually recognized and accepted by Chinese clinicians, and have been greatly concerned by the clinical workers of integrated Chinese and western medicine. In recent years, the results of many clinical trials have been published. Some studies have also been recognized by the international academic community. In this issue, "opinions on some problems in the Clinical trial of Integrated Chinese and Western Medicine on Cardiovascular Diseases", on the basis of reviewing past experiences and lessons, the purpose of clinical trials of integrated traditional Chinese and western medicine on cardiovascular diseases in China is designed. Some suggestions are put forward in the aspects of implementation and application, which not only emphasize the scientific requirements of clinical trials, but also emphasize the construction of problems from the point of view of clinical needs, and consider the practicability of the results from the beginning. This is because the clinical trial of integrated traditional Chinese and western medicine is not a simple evaluation of the efficacy of a single drug, but aimed at exploring the best combination of two therapeutic approaches that have already been used in clinical practice, or to determine the best combination of traditional Chinese and western medicine. Therefore, this article not only for cardiovascular specialty, but also for other professional integrated Chinese and western medicine clinical trials also have certain reference value.
【作者單位】： 中國中西醫(yī)結合學會心血管病專業(yè)委員會;
【分類號】：R54

【相似文獻】

相關期刊論文 前10條

1 常波;單麗沈;王云寧;馮軍;單丹妮;劉春峰;;中西醫(yī)結合治療功能性復發(fā)性腹痛療效分析[J];大連醫(yī)科大學學報;2009年03期

2 ;國內[J];中國處方藥;2010年08期

3 陳浩;史大卓;;近年臨床試驗及指南對中西醫(yī)結合治療冠心病的啟示[J];中西醫(yī)結合心腦血管病雜志;2009年04期

4 范維琥;戴瑞鴻;;中西醫(yī)結合治療冠心病的創(chuàng)新之路[J];上海醫(yī)藥;2010年01期

5 胡大一;運用循證醫(yī)學的新證據指導心血管疾病防治實踐[J];中華醫(yī)學信息導報;2005年22期

6 黃漢超;周鳳嬌;陳宏s，

本文編號：1931942